Mereo Biopharma Group Plc's total assets for Q4 2025 were $45.92M, a decrease of -14.34% from the previous quarter. MREO total liabilities were $5.00M for the fiscal quarter, a -28.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.